CFAGX
Price
$36.75
Change
-$0.40 (-1.08%)
Updated
Jul 24 closing price
Net Assets
118.57M
JDMAX
Price
$142.12
Change
-$0.06 (-0.04%)
Updated
Jul 23 closing price
Net Assets
22.4B
Interact to see
Advertisement

CFAGX vs JDMAX

CFAGX vs JDMAX Comparison Chart in %
View a ticker or compare two or three
VS
CFAGX vs. JDMAX commentary
Jul 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CFAGX is a Buy and JDMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JDMAX has more cash in the bank: 22.4B vs. CFAGX (119M). CFAGX pays higher dividends than JDMAX: CFAGX (0.07) vs JDMAX (0.00). CFAGX was incepted earlier than JDMAX: CFAGX (32 years) vs JDMAX (17 years). JDMAX (1.14) is less costly to investors than CFAGX (0.84). CFAGX is a more actively managed with annual turnover of: 74.00 vs. JDMAX (17.00). CFAGX has a lower initial minimum investment than JDMAX: CFAGX (1000) vs JDMAX (2500). JDMAX annual gain was more profitable for investors over the last year : 0.94 vs. CFAGX (-21.71). JDMAX return over 5 years is better than : -15.46 vs. CFAGX (-35.51).
CFAGXJDMAXCFAGX / JDMAX
Total Expense Ratio0.841.1474%
Annual Report Gross Expense Ratio0.841.1474%
Fund Existence32 years17 years-
Gain YTD3.4706.85751%
Front LoadN/A6%-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets119M22.4B1%
Annual Yield % from dividends0.070.00-
Returns for 1 year-21.710.94-2,316%
Returns for 3 years-15.468.47-183%
Returns for 5 years-35.51-15.46230%
Returns for 10 years6.4054.6212%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GLNIX25.74N/A
N/A
MFS Global New Discovery I
WTSGX26.88N/A
N/A
Segall Bryant & Hamill Small Cap Gr Ret
PDRDX13.82N/A
N/A
Principal Diversified Real Asset Instl
FIWCX14.64N/A
N/A
Fidelity SAI International Value Index
PXSIX22.55-0.21
-0.92%
Impax Small Cap Institutional